Our investment thesis is simple. The world is decades behind in pandemic preparedness. We aim to fix that.
As early-stage, tech investors we look for U.S. based companies with defensible and scalable software, hardware, and deep tech solutions. In assessing these opportunities, we first look to our unifying investment themes.
We seek opportunities that help:
- find pandemics faster such as surveillance, testing, GIS and population health
- fix it faster such as drug development platforms, medical devices for drug delivery, and telemedicine
- make work, work or life work for that matter, such as disinfection technologies, remote collaboration tools, teleconnection, robotics, cybersecurity, and EDtech
- do better next time such as supply chain, process and manufacturing resilience, communication, and food security.
